ZhaoM, et al.Network meta-analysis of novel glucose-lowering drugs on risk of acute kidney injury. Clin J Am Soc Nephrol2021; 16:70–78. doi: https://doi.org/10.2215/CJN.11220720
SGLT2 Inhibitors as Protective for Acute Kidney Injury
Highlight of a recent study in CJASN, “Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury”
Huilin Tang
Huilin TangHuilin Tang, MS, is affiliated with the Institute for Drug Evaluation, Peking University Health Science Center. Study co-authors Min Zhao, MS, and Zhenguang Huang, MS, are affiliated with the Department of Pharmacy, The First Affiliated Hospital of Guangxi Medical University; Shusen Sun, PharmD, with the College of Pharmacy and Health Sciences, Western New England University; and Tiansheng Wang, PharmD, with the Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill.